Wealth Science Advisors’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$527K Sell
2,295
-73
-3% -$15.1K 0.22% 50
2026
Q2
$371K Buy
2,368
+2,218
+1,479% +$390K 0.16% 72
2026
Q1
$39.7K Buy
+150
New +$31.1K 0.02% 107

Other funds holding CRM

Wealth Science Advisors's CRM Position: Q3 2026 in Review

Wealth Science Advisors reduced its Salesforce (CRM) stake by 3.1% in Q3 2026, selling an estimated $15.1K and leaving 2,295 shares worth $527K. The position accounts for 0.22% of the portfolio, ranked #50.

Wealth Science Advisors first reported a position in CRM in Q1 2026 and has held it in 3 quarters since. 122 funds tracked by Wall St. Rank hold CRM as of Q3 2026.

  • Wealth Science Advisors held 2,295 shares of Salesforce worth $527K as of Q3 2026.
  • Wealth Science Advisors sold 73 Salesforce shares in Q3 2026, an estimated $15.1K.
  • Salesforce made up 0.22% of Wealth Science Advisors's portfolio in Q3 2026, its #50 holding.
  • Wealth Science Advisors first reported a position in Salesforce in Q1 2026 and has held it in 3 quarters since.
  • 122 funds tracked by Wall St. Rank held Salesforce as of Q3 2026.

Based on Wealth Science Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.